Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > The “new strategy”

<< Previous

Bullboard Posts

Next >>

Comment by SPCEO1on Jul 14, 2021 12:49pm

157 Views

Post# 33542768

RE:RE:RE:The “new strategy”

WHile TH is a Canadian comapny it is no longer much of a Canadian stock as most of the trading volume is now in the US on NASDAQ. Most of the shareholders are also US based at this point too. So, if you want to trade your stock, you should have no problem trading it easily in the US on NASDAQ.

canadapiet wrote: All their "pr's" helped very well!!!
Look at the volume................, more than 100 shares.....!!!!
How in the world could i have sold my 9.500 shares for 4,80 ?????

Hope tomorow will be good ER....

luck and hope for all